VERAXA Taps Oncology Veteran Dr. Rick Austin as CSO to Propel Cancer Therapies

VERAXA Taps Oncology Veteran Dr. Rick Austin as CSO to Propel Cancer Therapies

Strategic Leadership for a New Era in Cancer Treatment VERAXA Biotech AG, an innovative Swiss company at the forefront of designing novel cancer therapies, today announced a significant enhancement to its leadership team with the appointment of Dr. Rick Austin as its new Chief Scientific Officer. The appointment, effective May 1st, 2025, comes as VERAXA…

Tech Layoffs Mount in May 2025 as AI's Role Sparks Debate

Tech Layoffs Mount in May 2025 as AI’s Role Sparks Debate

Tech Industry Grapples with Job Cuts in 2025 Less than six months into 2025, the technology industry is once again grappling with significant workforce reductions, continuing a trend from the previous year. According to data compiled by Layoffs.fyi, an independent tracker, over 50,000 tech employees have been laid off across the sector so far this…